Page last updated: 2024-10-27

fentanyl and Androgen-Independent Prostatic Cancer

fentanyl has been researched along with Androgen-Independent Prostatic Cancer in 2 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Westdorp, H1
Kuip, EJM1
van Oort, IM2
Kramers, C1
Gerritsen, WR1
Vissers, KCP1
Benoist, GE1
Burger, DM1
Koch, BCP1
Mehra, N1
van Erp, NP1

Other Studies

2 other studies available for fentanyl and Androgen-Independent Prostatic Cancer

ArticleYear
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer.
    Journal of pain and symptom management, 2018, Volume: 55, Issue:4

    Topics: Aged; Analgesics, Opioid; Antineoplastic Agents; Benzamides; Bone Neoplasms; Drug Interactions; Fent

2018
The Combination of Enzalutamide and Opioids: A Painful Pitfall?
    European urology, 2019, Volume: 75, Issue:2

    Topics: Analgesics, Opioid; Androgen Antagonists; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cytochr

2019